Heartflow CMO exercises options, sells 64K shares
Heartflow, Inc. Chief Medical Officer Campbell Rogers exercised stock options and sold shares of common stock.
Rhea-AI Filing Summary
Heartflow, Inc. Chief Medical Officer Campbell Rogers exercised stock options and sold shares of common stock. On April 1, 2026, he exercised options covering 67,017 shares of common stock at exercise prices of $2.22 and $8.33 per share and received the same number of common shares.
That day, he sold 64,533 shares of common stock at a weighted average price of $24.64 per share in open-market transactions, as part of a Rule 10b5-1 Trading Plan adopted on September 12, 2025. Following these transactions, he holds 81,002 shares directly, along with indirect holdings through several trusts, including 50,754 shares held by The Campbell Rogers Revocable Trust.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
13 txns
Insider
Rogers Campbell
Role
Chief Medical Officer
Sold
64,533 shs ($1.59M)
Approx. gross sale proceeds
$1.59M
Approx. exercise cost
$151K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options | 6,849 | $0.00 | $0.00 |
| Exercise | Stock Option | 291 | $0.00 | $0.00 |
| Exercise | Stock Option | 19,111 | $0.00 | $0.00 |
| Exercise | Stock Option | 40,766 | $0.00 | $0.00 |
| Exercise | Common Stock | 291 | $8.33 | $2K |
| Exercise | Common Stock | 19,111 | $2.22 | $42K |
| Exercise | Common Stock | 40,766 | $2.22 | $91K |
| Exercise | Common Stock | 6,849 | $2.22 | $15K |
| Sale | Common Stock | 64,533 | $24.64 | $1.59M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Options — 0 contracts (Direct);
Stock Option — 84,931 contracts (Direct);
Common Stock — 81,002 shares (Direct);
Common Stock — 22,615 shares (Indirect, By Campbell Rogers 2019 Irrevocable Trust);
Common Stock — 46,159 shares (Indirect, By CR Asset Protection Trust of 2023);
Common Stock — 26,012 shares (Indirect, By Spouse's Trust);
Common Stock — 50,754 shares (Indirect, By The Campbell Rogers Revocable Trust)
Footnotes (6)
- F1. The option exercise reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
- F2. The option exercise and sale reported on this Form 4 were effected pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
- F3. Includes the sale of 16,918 shares of common stock held and the option exercise and sale of 47,615 shares reported on this Form 4 that were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 12, 2025.
- F4. This transaction was executed in multiple trades at price ranging from $24.03 to $25.27. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F5. These stock options are fully exercisable.
- F6. The option vests and becomes exercisable in monthly installments until July 1, 2027, subject to continued service through the applicable vesting date.
Key Figures
Options Exercised: 67,017 shares
Exercise Prices: $2.22 and $8.33 per share
Shares Sold: 64,533 shares
+4 more
7 metrics
Options Exercised
67,017 shares
Stock option exercises on April 1, 2026
Exercise Prices
$2.22 and $8.33 per share
Conversion prices for exercised stock options
Shares Sold
64,533 shares
Open-market sale of common stock on April 1, 2026
Weighted Average Sale Price
$24.64 per share
Sale executed in trades from $24.03 to $25.27
Direct Holdings After
81,002 shares
Direct Heartflow common stock owned after transactions
Revocable Trust Holdings
50,754 shares
Indirect holdings by The Campbell Rogers Revocable Trust
Rule 10b5-1 Plan Adoption
September 12, 2025
Plan governing option exercises and sales
Key Terms
Rule 10b5-1 Trading Plan, stock options, weighted average sale price, open-market sale, +1 more
5 terms
Rule 10b5-1 Trading Plan regulatory
"effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
stock options financial
"These stock options are fully exercisable."
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
weighted average sale price financial
"The price reported above reflects the weighted average sale price."
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Heartflow (HTFL) Chief Medical Officer Campbell Rogers report in this Form 4?
Campbell Rogers reported exercising stock options for 67,017 Heartflow shares and selling 64,533 shares in open-market trades. The transactions occurred on April 1, 2026 and were executed under a pre-arranged Rule 10b5-1 trading plan adopted in September 2025.
Were Campbell Rogers’s Heartflow (HTFL) transactions made under a Rule 10b5-1 trading plan?
Yes. The Form 4 footnotes state the option exercises and related sales were effected under a Rule 10b5-1 trading plan. That plan was adopted by Rogers on September 12, 2025, indicating the transactions were pre-scheduled rather than timed discretionarily.
What are Campbell Rogers’s Heartflow (HTFL) holdings after these transactions?
After the April 1, 2026 transactions, Rogers holds 81,002 Heartflow shares directly. He also has indirect holdings through several trusts, including 50,754 shares held by The Campbell Rogers Revocable Trust and additional shares in other named family trusts.
What type of Heartflow (HTFL) insider activity does this Form 4 reflect overall?
The filing reflects an exercise-and-sell pattern. Rogers exercised stock options to acquire 67,017 shares, then sold 64,533 shares in open-market trades, while retaining a significant direct position and indirect trust holdings in Heartflow common stock after the transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
